Development asset linked to Tvardi Therapeutics in public FDA and regional records.
pharma · Squamous Cell Carcinoma of Head and Neck · Breast Cancer · TVRD
Tvardi Therapeutics
Tvardi Therapeutics drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Houston, USA HQ
2017 Founded
20 Employees
Public company Type
TVRD · NYSE Ticker
Company details
- Status
- Public
- HQ
- Houston, USA
- Founded
- 2017
- Employees
- 20
- Programs
- 6
- Drugs
- 2
- Patents
- 6
Tvardi Therapeutics pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Tvardi Therapeutics drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Tvardi Therapeutics in public FDA and regional records.